Status:
COMPLETED
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Sint Maartenskliniek
Conditions:
Psoriasis
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Rationale: Psoriasis (PsO) is a common inflammatory skin disease. Besides the skin, it is recognized that this disease can affect multiple domains such as nails, joints and entheses. About 30% of the ...
Detailed Description
This is a monocenter cohort study, which will span at least 1 year from inclusion to follow-up. A sample of 300 patients known with PsC (cutaneous psoriasis) at the Department of Dermatology of the R...
Eligibility Criteria
Inclusion
- Diagnosis of cutaneous psoriasis
- Age 18 years or above
- Willing and able to comply with visits and study-related procedures
- Provide signed informed consent (IC)
Exclusion
- Age below 18 years
- Unable to give IC
- Unable or unwilling to comply with visits and study-related procedures
- Participation in other trials involving PsO
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 28 2022
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT03816917
Start Date
June 1 2019
End Date
July 28 2022
Last Update
July 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Netherlands